There's still time to register for virtual attendance for tomorrow's "Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence," public workshop! Register today to learn more about the current state of gene therapy interventions: https://lnkd.in/em7t6zxn
Reagan-Udall Foundation for the FDA
Non-profit Organizations
Washington, DC 4,571 followers
Advance the mission of the FDA to modernize product development, accelerate innovation, and enhance product safety
Über uns
The Reagan-Udall Foundation is an independent 501(c)(3) not-for-profit organization created by Congress to advance the mission of the FDA by advancing regulatory science and research. With the ultimate goal of improving public health, the Foundation provides a unique opportunity to bring all parties to the table (FDA, Patient Groups, Academia, other Government entities, and Industry) to work together in a transparent way to create exciting new regulatory science.
- Website
-
http://www.reaganudall.org/
External link for Reagan-Udall Foundation for the FDA
- Industrie
- Non-profit Organizations
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Washington, DC
- Typ
- Nonprofit
- Gegründet
- 2007
- Spezialitäten
- Regulatory Science, Public Private Partnerships, Medical Evidence Development & Surveillance, and Public Health
Standorte
-
Primäre
Wegbeschreibung erhalten
1900 L Street NW
Suite 835
Washington, DC 20036, US
Employees at Reagan-Udall Foundation for the FDA
-
Susan Winckler
-
David Fajgenbaum, MD, MBA, MSc
Physician-Scientist @ UPenn | National Bestselling Author, Chasing My Cure | Co-Founder @ Every Cure & CDCN
-
Carla V. Rodriguez-Watson, PhD, MPH
Director of Research at Reagan-Udall Foundation for the FDA
-
Kathleen Spaeth
Brand Builder/Writer/Mar-Com Pro/Problem Solver
Aktualisierungen
-
The Reagan-Udall Foundation for the FDA is closed today in recognition of #LaborDay.
-
-
It's back to school season and new updates to school meals focus on giving kids the right balance of nutrients, while reducing the amounts of added sugars in menu items, especially at breakfast. Learn more about the gradual changes today! https://lnkd.in/ewRXvK4w
2024 Updates to the School Nutrition Standards – Overview
https://www.youtube.com/
-
Our "Advancing Treatments for Post-Traumatic Stress Disorder" hybrid public meeting will feature stakeholder comment from people with lived PTSD experience, including veterans, family members, and patient advocates; researchers and scientists; and drug developers. The deadline to request to present stakeholder comment is 12pm (eastern) on September 3. Register today and request to present stakeholder comment: https://lnkd.in/e7wY6GkN
-
-
#ExpandedAccess may be an option for patients with life-threatening diseases or conditions to try investigational medical products when no satisfactory or approved therapies are available and there is no opportunity for the patient to enroll in a clinical trial. Learn more about Expanded Access and how it can help your patients here: https://lnkd.in/dvgFxkS #physicians #healthcare
-
-
"Advancing Treatments for Post-Traumatic Stress Disorder" will feature a panel discussion with federal partners to explore efforts to accelerate treatment development for PTSD, including psychedelic drug development. Register today and request to present stakeholder comment: https://lnkd.in/e7wY6GkN FDA
-
-
The use of biomarkers to develop treatments for rare genetic diseases is an essential topic that warrants serious consideration. Learn more on page 1 of our "Qualifying Biomarkers to Support Rare Disease Regulatory Pathways" workshop summary: https://lnkd.in/ePdxb2NY Denali Therapeutics Orchard Therapeutics - U.S. REGENXBIO Inc. Ultragenyx
-
-
Our "Advancing Treatments for Post-Traumatic Stress Disorder" hybrid public meeting will feature stakeholder comment from people with lived PTSD experience, including veterans, family members, and patient advocates; researchers and scientists; and drug developers. Please note that the deadline to request to present stakeholder comment is 12pm (eastern) on September 3. Register today and request to present stakeholder comment: https://lnkd.in/e7wY6GkN FDA
-
-
Foundation Program Coordinator Georgia Peeples joins Foundation Research Director Carla V. Rodriguez-Watson, PhD, MPH, Foundation Research Scientist Hsiao-Ching Huang, MPH PhD, and a few of her fellow co-authors as she displays her poster covering the scope and scale of the IMEDS Network for conducting real-world pharmacoepidemiologic studies in pregnancy during the International Society for Pharmacoepidemiology's #ISPE2024 Annual Meeting in Berlin.
-
-
Reagan-Udall Foundation for the FDA reposted this
Join the FDA and the Reagan-Udall Foundation for the FDA for a hybrid public meeting on September 6, 2024 to discuss efforts to accelerate treatment development for Post-Traumatic Stress Disorder (PTSD), including psychedelic drug development. Register today: https://lnkd.in/gUKinWt6
-